[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2): 115-132. [2] Bray F, Ferlay J,Soerjomataram I, et al.Global cancer statistics 2018: GLOBACAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [3] Fu H, Yang H, Zhang X, et al.Exosomal TRIM3 is a novel marker and therapy target for gastric cancer[J]. J Exp Clin Cancer Res, 2018, 37(1): 15-25. [4] Tuanjie Li, Qi Zhang, Yuming Jiang, et al.Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2[J]. Oncoimmunology, 2016, 5(2): e1069936. [5] Gu J, Ren L, Wang X,et al.Expression of livin, survivin and caspase-3 in prostatic cancer and their clinical significance[J]. Int J Clin Exp Pathol, 2015, 8(11): 14034-14039. [6] Wang X, Fu Z, Chen Y, Liu L.Fas expression is downregulated in gastric cancer[J]. Mol Med Rep, 2017, 15(2): 627-634. [7] He X, Wu J, Yuan L,et al.Lead induces apoptosis in mouse TM3 Leydig cells through the Fas/FasL death receptor pathway[J]. Environ Toxicol Pharmacol,2017, 56:95-105. [8] 李晨龙,常亮,郭林,等. 姜黄素通过Fas/FasL信号通路调控胶质瘤细胞增殖和凋亡[J]. 中国微侵袭神经外科杂志,2015, 20(5):222-226. [9] Szarynska M,Olejniczak A, Wierzbicki P,et al.FasR and FasL in colorectal cancer[J]. Int J Oncol,2017,51(3):975-986. [10] Huang R, Zhang D, Li F,et al.Loss of Fas expression and high expression of HLA-E promoting the immune escape of early colorectal cancer cells[J]. Oncol Lett,2017,13(5):3379-3386. [11] Zhao T, Xu Y, Ren S,et al.The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells[J]. Exp Ther Med,2018,15(5):4370-4378. [12] Yajima T, Hoshino K, Muranushi R,et al.Fas/FasL signaling is critical for the survival of exhausted antigen-specific CD8+ T cells during tumor immune response[J]. Mol Immunol,2019,3(107):97-105. |